A new mouse esophageal cancer cell line (mEC25)‐derived pre‐clinical syngeneic tumor model for immunotherapy
Main Authors: | Tuxiong Huang, Jiao Yang, Beilei Liu, Li Fu |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-07-01
|
Series: | Cancer Communications |
Subjects: | |
Online Access: | https://doi.org/10.1002/cac2.12066 |
Similar Items
-
Application of immunotherapy based on dendritic cells stimulated by tumor cell-derived exosomes in a syngeneic breast tumor mouse model
by: Yin Ji Piao, et al.
Published: (2021-12-01) -
Comparing syngeneic and autochthonous models of breast cancer to identify tumor immune components that correlate with response to immunotherapy in breast cancer
by: Jessica Castrillon Lal, et al.
Published: (2021-08-01) -
Biogenicity and Syngeneity of Organic Matter in Ancient Sedimentary Rocks: Recent Advances in the Search for Evidence of Past Life
by: Dorothy Z. Oehler, et al.
Published: (2014-08-01) -
Efficacy of Combination Chemotherapy Using a Novel Oral Chemotherapeutic Agent, FTD/TPI, with Ramucirumab Murine Version DC101 in a Mouse Syngeneic Cancer Transplantation Model
by: Kenta Tsunekuni, et al.
Published: (2020-12-01) -
A Set of Cell Lines Derived from a Genetic Murine Glioblastoma Model Recapitulates Molecular and Morphological Characteristics of Human Tumors
by: Barbara Costa, et al.
Published: (2021-01-01)